TrialCirculation2026

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.

Christian Spaulding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.